Lu Li, MD

Research interests: lung cancer, immunotherapy, Target therapy

Lu Li, MD, PhD, is associate professor and deputy chief physician of Lung Cancer Center, West China Hospital of Sichuan University in Chengdu, China. She specializes in neoadjuvant therapy, adjuvant therapy and multiple discipline treatments for advanced lung cancer, including but not limited to chemotherapy, immunotherapy and target therapy, etc. She has participated in many GCP clinical trials as a project leader. She is the Chairman of the Youth Committee of the Lung Cancer Special Committee, Sichuan Anti-Cancer Association and Vice Chairman of Lung Cancer Special Committee, Sichuan Anti-Cancer Association. She committed to the study of immunotherapy and the mechanism of drug resistance recently.

Editorial Board
Terms of Appointment: July 2022 - June 2023;  August 2023 - July 2024